Vaccination and Censorship: The Truth Will Set Us Free
On Dec. 22, 2020, a non-profit limited company based in Great Britain that calls itself the Center for Countering Digital Hate (CCDH) published a report entitled The Anti-Vaxx Playbook. It contains false and misleading information about the Fifth International Public Conference on Vaccination, which was sponsored by the 39-year old U.S. non-profit educational charity the National Vaccine […]
National Vaccine Information Center Opens Vaccine Conference for Free Viewing Online
On Feb. 2, 2021, the U.S. non-profit charity the National Vaccine Information Center (NVIC) opened the Fifth International Public Conference on Vaccination: Protecting Health and Autonomy in the 21st Century for free online viewing. The 39-year old educational organization sponsored the three-day digital pay-for-view public conference in October 2020, which features video presentations by 51 […]
AstraZeneca’s COVID-19 Vaccine Not Recommended for People Over 65 in Germany
Health officials in Germany have cautioned that the AstraZeneca/Oxford University COVID-19 vaccine (AZD1222) should not be given to people over the age of 65. Germany’s disease control agency, the Robert Koch Institute, only recommends the shot for people between the ages of 18-64 after concluding that there is not enough data available to determine whether the […]
Minority Populations Targeted for Early COVID-19 Vaccination
Story Highlights Minority populations including Blacks, Hispanics and Native Americans have been disproportionately affected by COVID-19 in the U.S., with evidence indicating they have a higher risk of being infected and/or are at an increased risk of serious disease and death from the infection. Many agencies, public figures and states are advocating that such at-risk […]
Moderna, Pfizer Test mRNA Experimental Biologics on Children
On Dec. 10, 2020, American biotechnology company Moderna, Inc., which is pioneering the development of experimental messenger RNA (mRNA) therapeutics and vaccines, gave a 12-year old a dose of the company’s mRNA-1273 vaccine in a Phase 2/3 study of the new vaccine. Moderna CEO Stephane Bancel said, “Our goal is to generate data in the […]